Creasey W A, Morrison R A, Singhvi S M, Willard D A
E.R. Squibb and Sons, Inc., Princeton, New Jersey 08540.
Eur J Clin Pharmacol. 1988;35(4):367-70. doi: 10.1007/BF00561366.
The pharmacokinetic characteristics of intravenously-administered captopril were investigated in 7 healthy men 20 to 33 years old. Capropril, labeled with 14C, was given by injection over a 1 min period at mean doses of 2.78 mg (13.8 microCi), 5.67 mg (28.2 microCi) and 11.4 mg (56.8 microCi). Concentrations of unchanged captopril, captopril disulfide, and other metabolites (collectively) were determined in body fluids. Pharmacokinetic parameters were calculated for unchanged captopril, and it was shown that the disposition of intravenously-administered drug was linear with respect to dose over the dosage range studied.
